000 01432 a2200397 4500
005 20250516111615.0
264 0 _c20130819
008 201308s 0 0 eng d
022 _a1935-5548
024 7 _a10.2337/dc12-1323
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aValenzuela-Silva, Carmen M
245 0 0 _aGranulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.
_h[electronic resource]
260 _bDiabetes care
_cFeb 2013
300 _a210-5 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aDiabetic Foot
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aEpidermal Growth Factor
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
650 0 4 _aWound Healing
_xdrug effects
700 1 _aTuero-Iglesias, Ángela D
700 1 _aGarcía-Iglesias, Elizeth
700 1 _aGonzález-Díaz, Odalys
700 1 _aDel Río-Martín, Amaurys
700 1 _aYera Alos, Isis Belkis
700 1 _aFernández-Montequín, José I
700 1 _aLópez-Saura, Pedro A
773 0 _tDiabetes care
_gvol. 36
_gno. 2
_gp. 210-5
856 4 0 _uhttps://doi.org/10.2337/dc12-1323
_zAvailable from publisher's website
999 _c22093598
_d22093598